Cytori bags Azaya drugs in asset purchase; Woodford offers a mea culpa on Northwest Bio
• Cytori is adding a pair of oncology drugs to its portfolio with the acquisitions of assets from San Antonio-based Azaya. Azaya has been at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
